Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
出版年份 2016 全文链接
标题
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 108, Issue 9, Pages djw050
出版商
Oxford University Press (OUP)
发表日期
2016-04-30
DOI
10.1093/jnci/djw050
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
- (2016) Robert C Stein et al. HEALTH TECHNOLOGY ASSESSMENT
- The agreement chart
- (2013) Shrikant I Bangdiwala et al. BMC Medical Research Methodology
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
- (2012) G C Wishart et al. BRITISH JOURNAL OF CANCER
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
- (2012) S. K. Chia et al. CLINICAL CANCER RESEARCH
- Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial
- (2012) J. Bartlett et al. CLINICAL ONCOLOGY
- Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier in Early-Stage Estrogen Receptor-Positive Breast Cancer
- (2012) C. M. Kelly et al. ONCOLOGIST
- A population-based validation of the prognostic model PREDICT for early breast cancer
- (2011) G.C. Wishart et al. EJSO
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial
- (2011) John M.S. Bartlett et al. JOURNAL OF CLINICAL ONCOLOGY
- Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement
- (2011) Alan Mackay et al. JNCI-Journal of the National Cancer Institute
- Practical implications of gene-expression-based assays for breast oncologists
- (2011) Aleix Prat et al. Nature Reviews Clinical Oncology
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now